Robert Adelman Akero Therapeutics, Inc

As of July 6, 2020


Robert Adelman Net Worth

  • Net worth is estimated to be at least $254.4M
  • Owns at least 3,033,552 units of Akero Therapeutics, Inc stock
  • Sold an estimated value of $21.09M in the last year at Akero Therapeutics, Inc

Robert Adelman Trading

  • Largest purchase of shares was 3,954,858 units , worth over $4M on June 25, 2019
  • Largest sale of shares was 494,000 units , worth over $9.99M on January 14, 2020
  • In total has made about 13 transactions over a year
  • Usually trades in January, with the busiest year in 2020

venBio Global Strategic Fund II LP, venBio Global Strategic GP II LP, venBio Global Strategic GP II Ltd, Robert Adelman, COREY GOODMAN

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Robert Adelman Mailing Address

  • Mailing address is 1700 Owens Street Suite 595 San Francisco CA 94158 CA

Akero Therapeutics, Inc Insider Trading

  • The most recent transaction was 12,500 units sold on September 17, 2021 by Catriona Yale worth over $308.61K
  • In the last 2 years, insiders at Akero Therapeutics, Inc sold an estimated value of $42.38M and bought an estimated value of $82.54M
  • The most active traders are Jonathan Young, Chief Operating Officer,  Corey Goodman,  and Robert Adelman
  • Insider trading is most common in June, with the busiest year in 2020

Akero Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1